We initiate coverage on Park Medi World (Park) with BUY and Mar-27E TP of Rs350 (37% upside), based on 21x Mar-28E EBITDA (in line with sector average). Park’s differentiated business model and lean cost structure allow it to deliver quality care at accessible prices.